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La legalización de la marihuana es una tendencia que ha ido en aumento en la última 
década en el occidente. La influencia de esta tendencia también ha llegado a Ecuador, donde 
las autoridades están trabajando actualmente en un proyecto de ley que legalizaría la cosecha, 
venta y consumo de marihuana medicinal. Por esta razón, es imperativo estudiar cómo el 
consumo crónico de marihuana afecta procesos neuropsicológicos, específicamente las 
funciones ejecutivas, de los adolescentes, ahora adultos emergentes. Algunos estudios recientes 
han encontrado una correlación existente del consumo de marihuana y deterioro en algunos 
procesos cerebrales. Aún así, no hay suficiente información específica sobre cómo se ven 
afectadas las funciones ejecutivas, razón por la cual el propósito principal de este estudio es 
evaluar las funciones ejecutivas en los usuarios crónicos de Cannabis sativa. Treinta 
participantes ecuatorianos que personalmente reportan tener problemas con un trastorno de 
consumo de marihuana serán reclutados para ser parte de la investigación, el cual se definirá 
como el uso de marihuana más días que no durante los últimos tres años. Basado en la revisión 
de literatura, se espera encontrar un deterioro global o específico por área en el funcionamiento 
ejecutivo de los participantes. 
 
 





The legalization of marijuana is a trend that has been increasing in the last decade 
around the West. The trend’s influence has also reached Ecuador, where authorities are 
currently working on a law project that would legalize the harvesting, selling and consumption 
of medical marijuana. For this reason, it is imperative to study how the chronic smoking of 
marijuana is affecting the neuropsychological processes, specifically executive functions, of 
teenagers, now emerging adults. Some recent studies have found an existing correlation of 
consumption of marijuana and impairment on some brain processes. However, there is not 
enough information specifically targeting how executive functions are affected, which is why 
the main purpose of this study is to assess executive functions on chronic Cannabis sativa 
users. Thirty Ecuadorian participants who personally report having problems with marijuana 
use disorder will be recruited to be a part of the research, which will be defined as using 
marijuana more days than not for the past three years. Based on the literature review, it is 
expected to find global or area-specific impairment on the participants’ executive functioning. 
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For almost a century, substance abuse around the globe has become a major public 
health concern. Starting in the 1950s, the use of recreational drugs turned an already growing 
epidemic into a global health crisis. According to the National Survey on Drug Use and 
Health, around 20.5% of Americans aged 12 or older had been diagnosed with a substance 
use or abuse disorder in 2016 (Substance Abuse and Mental Health Services Administration, 
2017). These numbers include the use of alcohol and other illicit drugs at the time, such as 
marijuana, cocaine, heroin, hallucinogens, inhalants, methamphetamine and others. The 
American Psychiatric Association (2013) defines Substance Use Disorder as “a cluster of 
cognitive, behavioral, and physiological symptoms indicating that the individual continues 
using the substance despite significant substance-related problems”.   
Although defining addiction in a specific and universal manner is challenging, Fields 
(2007) defines addiction based on two models: the choice and the disease model. The choice 
model states that the consumption of alcohol or other drugs is merely a choice by the user, 
which can probably be stopped whenever the user decides. On the other hand, the disease 
model states that addiction is, in fact, a chronic and progressive disease, presenting 
psychological and physical dependence. These definitions and models are currently used to 
diagnose and find the best intervention for a substance user.  
Furthermore, research has shown that there are many possible causes for addiction. 
Regarding each model mentioned above, some causes of addiction can be stress-related 
experiences, like trauma; biological/genetic predisposition or even an insecure attachment to 
the person’s primary caregiver. The attachment or parent-child bonding theory is widely used 




there is a poor bond with a parent. “The child may even suffer from depression as a result of 
times when he or she felt abandoned or rejected” (Fields, 2007).  
Moreover, the legalization of marijuana is a trend that has been increasing in the last 
decade around the West. Currently, medical marijuana is legal in 28 states out of fifty states, 
as well as the District of Columbia and Puerto Rico (Rubin, 2017) in the United States. In a 
closer cultural context, recreational and medical marijuana has been legal in Uruguay since 
2014, being the first country in the region that has allowed its citizens to harvest, sell and 
consume the drug (Traversa, 2019). The trend’s influence has also reached Ecuador, where 
authorities are currently working on a law project that would legalize the harvesting, selling 
and consumption of medical marijuana. Although at the moment the law has not passed yet, 
Ecuadorians will be ready in a near future to treat some chronic diseases like cancer, AIDS, 
fibromyalgia and arthritis with marijuana, increasing the use of the drug within the 
population. 
In Ecuador, there is few information on substance use disorders. Most research and 
surveys are focused on the use or abuse of alcohol. However, the use of recreational and hard 
drugs is also affecting Ecuador's population, despite the lack of research on it. Specifically, 
the use of marijuana is currently limited to a certain personal-use amount, while the 
production and selling is not legal. The Ecuadorian government has created a possession 
table that specifies the amount of drug that a person can legally hold, which is 10 grams for 
marijuana, 2 grams for cocaine base, 1 gram for cocaine, 0.1 grams for heroin, 0.015 grams 
for ecstasy and 0.040 grams for amphetamines (Delgado & Muentes, 2018). Public opinion 
suggests that this table has enabled teenagers to use illicit drugs more often and with more 




For this reason, it is imperative to study how the chronic smoking of marijuana is 
affecting the neuropsychological processes, specifically executive functions, of teenagers, 
now emerging adults. Hence, the current study aims to respond to the question, “how and to 
what extent does marijuana affect the executive functions in the Ecuadorian emerging adults 
that meet the criteria for chronic use of marijuana?”. 
Objectives 
This research aims to establish whether there is a relationship between chronic use of 
marijuana and executive functioning. The hypothesis of the current experiment states that 
marijuana use distorts executive functioning in participants, which means that it affects their 
behavioral inhibition, working memory and cognitive flexibility. Consequently, the main 
general objective of this research is to state how drugs are affecting people’s body and minds, 
and marijuana is not an exception. Specific objectives include addressing of the problem 
exclusively in relation to executive functions, since there are some studies that conclude that 
marijuana affects cognitive processes in a broad way only. Also, this research will open 
possibilities to continue some studies on neurocognitive rehabilitation for these patients, 
jointly with psychotherapy. 
Significance 
There is limited research on the use and consequences of marijuana consumption in 
Ecuador. Drug use is common among teenagers around the world and research has shown 
that most drugs cause significant impairment in the human brain. However, most studies are 
outdated and have not found any relationship between the use of marijuana and cognitive 
processes. As time goes by, the legalization of marijuana is increasing worldwide, which also 
increases the interest of scientists to study its effects on brain processes. As a result, some 




impairment on some brain processes. Still, there is not enough information exclusively on 
how executive functions are affected, and currently, society has little information on what the 
mental risks on the use of marijuana are, even less so in Ecuador. 
Literature Review 
Drugs and Alcohol 
Sixty years ago, the true uprising of drugs started in the modern world. What 
historically was used to treat some medical diseases in a natural way by our ancestors, 
became the top hits for social movements of the era. Different types of drugs have their 
revolution in different decades throughout the last sixty years. Marijuana and hallucinogens, 
for instance, started to hit the streets and public meetings in the 1960s and 1970s, 
respectively, with the development of the hippie movement. These drugs were used by young 
people as a form of rebellion against the traditional values and civil violations. Whereas 
cocaine and synthetically produced drugs increased their popularity in the 1980s (Fields, 
2007). In the beginning, cocaine was believed to cause psychological dependence only, but in 
the next years, its popularity brought addiction scientists big doubts on that belief, changing 
the concept and study of addiction in a whole way. By that time, laws were restricting the use 
and commercialization of these new drugs, which is why underground chemically modified 
drugs started to become popular, as way to trick the chemical composition of those banned 
drugs (Fields, 2007). 
On the other hand, the history of alcohol in our society is way older compared to the 
history of other drugs. As yeast is the responsible for fermenting fruits in nature, it is believed 
that even our ancestor, the Homo Sapiens had contact with fermented fruits that were more 
appetizing and interesting than the rest of the fruits available in trees. Also, various chemical 




based on fruits, rice and honey, almost like the wine we know today (Curry, 2017). Given 
alcohol’s long story, its development into our modern society has been influenced by a lot of 
changes and adaptations, like different flavors, types, recipes, techniques and uses. Many 
years ago, alcohol was used by tribe leaders in order to obtain creativity and wisdom, as well 
as take advantages of its medical properties (Miller, 2014). Nowadays, alcohol is present in 
every aspect of popular culture, such as music, television, parties, movies, politics, social 
media and even religion, leading to “an unhealthy glorification of alcohol that encourages 
dangerous drinking habits” (Hoeg, 2019), along with other daily life use legal drugs that are 
also affecting the population.  
Types of drugs 
In order to understand the main differences between drugs, a brief classification of 
most used and well-known drugs is reviewed. Through the following classification, drugs are 
grouped based on the effects that they have in the Central Nervous System (CNS), in which 
we will find CNS depressants, CNS stimulants, hallucinogens, Cannabis sativa, and others. 
CNS Depressants 
The central nervous system depressants are known because of their high interaction 
with endorphins and GABA neurotransmitter in the brain. The effects of each drug may vary, 
but generally their main properties include: sedation, muscular relaxation, anxiolytics, 
anesthetic and anticonvulsive. These effects are caused mainly because of a decrease in blood 
pressure, heart rate, respiration rate and awareness. Larger doses alter perception and cause a 
decrease in brain functions and physical coordination, such as lethargy (Fields, 2007). An 
overdose of CNS depressants may even cause death, since the whole brain shuts down and is 
filled with inhibitory neurotransmitters, which eventually will reach vital areas such as the 
brain stem, where the cardiac and respiratory control areas rely. Alcohol, heroin, opiates and 





The central nervous system stimulants have the opposite characteristics as the CNS 
depressants. These drugs mainly interact with serotonin, dopamine and norepinephrine inside 
the central nervous system, neurotransmitters responsible for brain cell connections, reward 
pathways and sympathetic nervous system activations. The main effects of these drugs 
include increased blood pressure, heart rate, respiration rate, awareness and alertness, 
talkativeness and excitement; as well as decrease in appetite, fatigue and boredom (Fields, 
2007). An overdose of these drugs may excessively activate physical symptoms, especially 
those regarding the cardiovascular system, which can lead to arrythmias and heart attack. The 
drugs within this category are amphetamines, cocaine, crack, nicotine and caffeine.  
Hallucinogens 
These drugs are characterized for their psychedelic, psychotomimetic and 
psychotogenic properties. This means that they alter consciousness, mimic and produce 
psychosis (Fields, 2007). The main effects of these drugs include perception alteration, 
changing of feelings and emotions, flashes of light and hallucinations. However, there are 
several reports in which the effects of hallucinogens are very wide and can vastly vary 
depending on the context, the expectations and each personality. The main drugs that are 
included in this group are LSD and DMT available in some mushrooms, cactus and 
laboratory components. 
Cannabis sativa 
Although marijuana seems to fit best inside the category of hallucinogens related to 
its effects, there is a controversy in the last years about its categorization. A long time ago, it 
was believed that it belonged in this group, but the routes of administration, major effects, 
and possible damages differentiate it from the mentioned group. This is why, currently, all 




understanding of this categorization and the characteristics of marijuana is key to recognize 
the relationship it has with brain processes and executive functions, hence, the importance of 
this study.  
There are more than 300 cannabinoids that have been synthetized from the Cannabis 
plant (Fields, 2007). The most active component found in the plant is called 
tetrahydrocannabinol (THC), which varies between the different types of plants that are 
consumed now. The more concentration of THC present in the plant, the more intense effects 
it produces. The effects that THC produces in the body include intensification of thoughts 
and feelings, relaxation, minor increase in heart rate, increased appetite, altered states of time 
and space and impaired short-term memory (Fields, 2007). Nevertheless, it is important to 
realize that these effects also vary a lot depending on the person, potency of the drug, the 
route of administration and expectation. This means that marijuana can induce depressant, 
stimulant and/or hallucinogen effects.  
The variety of effects that marijuana has in the human body are primarily explained 
by the direct interaction of the cannabinoid with the endocannabinoid receptors (CB1 and 
CB2) in our human brain and other tissues. The endocannabinoid system, as it is named, is 
present in the CNS, peripheral nerves, blood cells, spleen, uterus and testicles (Du Plessis, 
Agarwal & Syriac, 2015). These receptors act with a G-protein, therefore, they can inhibit c-
AMP or calcium channels. Also, the CB1 receptors are the ones that have been related to 
THC in the human body, since this type of receptors are mainly in the CNS. The union of 
THC in the CB1 receptor in the presynaptic neuron will cause a modulation of GABA 
neurotransmitter, which is an inhibitory substance for our brain cells (Harvey, 2012). 
Marijuana is currently used for medical treatments in several countries worldwide. Its 




pain syndromes and glaucoma (Seamon, Fass, Maniscalco-Feichtl & Abu-Shraie, 2007). The 
increasing research programs on marijuana nowadays are giving promising results on the 
action that this substance can have when used under medical prescription and controlled 
doses. Other components, for example cannabidiol (CBD), are believed to lack the 
psychoactive effects of marijuana, which makes it a promising cannabinoid that will be used 
more in medical and psychiatric treatments like anxiety, chronic pain, mood symptoms and 
sleep complaints (Rong et al., 2017). 
Conversely, the uncontrolled and chronic use of marijuana may lead to several 
adverse effects. Most of these effects are physical, while other cognitive effects are still 
controversy in research. The main effects of the use of chronic marijuana are related to a 
strong psychological dependence, withdrawal symptoms including irritability, restlessness, 
nausea, headaches, anxiety, and panic reactions (Fields, 2007). Concerning the physical 
adverse effects, there are reports of damage to the respiratory system like bronchial problems, 
sore throat and chronic coughing, immune system deficiency, cardiac effects including 
tachycardia, hypertension and syncope, and reproductive system effects such as decreased 
sperm motility and altered hormone levels in both genders. Also, most of marijuana smoke 
“contains 50-70% more carcinogenic ingredients than cigarette smoke that can lead to lung 
cancer” (Seamon et al., 2007). 
Substance use and addiction 
The term addiction or dependence has been part of the psychological treatment area 
for many years. However, the DSM-5 has not included the term as a separate disorder in the 
new edition (contrary to the DSM-IV) since it can be prone to subjectivism between 
evaluators, therapists and other health professionals. Its main goal was to increase their 




substance dependence, substance abuse and substance intoxication. Still, in the new edition, 
substance dependence and substance abuse disorders were merged into one single diagnosis, 
substance use disorder (American Psychiatric Association, 2013).  
Substance-related and addictive disorders inside the DSM-5 include ten different 
types of drugs such as: alcohol, tobacco, caffeine, cannabis, opioids, hallucinogens, 
stimulants, sedatives, hypnotics and anxiolytics, inhalants, and others. The list of substance-
related and addictive disorders includes those diagnosis that are identified by the 
consumption of the drug and those that are induced by the drug, such as withdrawal 
syndromes (American Psychiatric Association, 2013). Currently, the assessment and positive 
diagnosis for a substance use disorder takes into account a pathological pattern of behaviors 
that are related to the consumption of the substance. Also, the use of specifiers for the 
severity of substance use disorder is the one who will let professionals understand in which 
state of the substance use the patient is at the moment. 
Still, there are some core characteristics of addiction that have been defined, which 
can increase interrater reliability within the addiction’s treatment area. Fields (2007) 
describes three basic components of the addiction, analyzing from a behavioral perspective, 
defined as the three Cs: compulsion, control and consequences. The first one, the obsessive-
compulsive behavior with the substance, is described as a vicious cycle where users have an 
obsessive concern about the use of the substance, followed by an incessant use characterized 
as a compulsion. The second one is described as an inability to stop consuming the substance 
for at least 3 months and having failed attempts to cut it back. The third one is characterized 
as a continued use despite adverse consequences, which are usually influenced by some 




The same characteristics have been taken into account when creating the DSM-5 
criteria for substance use disorder. The criteria can be applied to the 10 different types of 
drugs mentioned, except for coffee. There are 11 criteria explaining the “problematic pattern 
of substance use leading to a clinically significant impairment or distress …” (American 
Psychiatric Association, 2013). The user needs to manifest this pattern by at least two of the 
criteria within a 12-month period. The first criterion refers to the user consuming larger 
amounts of the substance, or over a longer period than was intended. The second criterion 
refers to the presence of a persistent desire or unsuccessful efforts to cut down or control the 
use. The third criterion refers to the investment of a big amount of time in activities to obtain 
or use the substance or recover from its effects. The fourth criterion refers to the presence of 
craving or strong desire to use the drug. The fifth criterion depicts a recurrent consumption 
which affects responsibilities at home, school or workplace. The sixth criterion describes the 
behavior as a continued use despite having persistent problems because of the drug. The 
seventh criterion states giving up or reducing important activities in order to use the drug. 
The eight criterion refers to a recurrent use in situations where it is dangerous to do so. The 
ninth criterion states that the use is continued despite knowledge of having a problem with 
the substance. The tenth criterion defines the presence of tolerance, which is defined by the 
need of increased amounts to achieve intoxication or desired effect, or a diminished effect 
when using the same amount of the drug as before. Finally, the last criterion states the 
presence of withdrawal, which is defined by complying criteria for withdrawal syndrome, or 
using drugs in order to relieve or avoid its symptoms (American Psychiatric Association, 
2013). 
 Etiology: risk and protective factors 
Seeing addiction as a process, there are several determinants at the base that are 




gender is a risk factor for substance use. Males are more likely to consume alcohol and 
marijuana, especially during young adulthood (Stone, Becker, Huber & Catalano, 2012). This 
results also show that men are 1.4 times more likely to initiate the consumption and then 
advancing into heavier stages, like addiction. Race/ethnicity is another risk factor that shown 
to be associated with substance use disorder. A number of studies have also shown that 
Caucasians have an increased risk of experiencing a substance use disorder in young 
adulthood more than any other ethnic group. The group of Hispanics is the most relevant for 
the purpose of this study, being the least likely group to experience a substance use disorder 
when transitioning from abstaining in early adolescence to regular use during young 
adulthood (Gil, Wagner & Tubman, 2004).  
Additionally, other factors influence on the reward circuit of neurotransmitters, 
precisely the dopaminergic circuits in the brain (Volkow et al., 2011). Mainly, the 
mesolimbic dopamine pathway is the responsible for the drug reward processes that are key 
to understanding the neuropsychological aspect of addiction. Several drugs, such as 
stimulants, nicotine, alcohol and marijuana have effects on these neurotransmitters, 
increasing the concentrations of dopamine in the circuits, thus, triggering a high or euphoria 
(Volkow et al., 2011). So, there are genetic factors that contribute to the transition from using 
a drug and being addicted, which are related to the dopaminergic pathways in the brain. 
Research has shown a genetic vulnerability for substance use disorders and dependence that 
is not only affecting the dopaminergic circuits, but also other neurotransmitters such as 
serotonin and GABA (Stone et al., 2012). This genetic influence is not caused by a single 
allele but by two different variations of alleles, which are transmitted throughout generations. 
Considering the relationship of addiction and the family system, education and 




“The most successful preventive approach is not to use drugs and alcohol, especially at early 
ages” (Fields, 2007). This means that parents have a crucial work in preventing children from 
becoming substance users or dependents in their future if they comply with several 
characteristics, such as not modeling substance use as a healthy approach, promoting positive 
activities, providing structure and discipline as well as encouraging consistent rules and 
family norms (Fields, 2007). Factors that encourage a healthy lifestyle and discourage drug 
use are considered as protective factors, the opposite to risk factors. High quality attachment 
or parent-child bonding is a protective factor, just like high education level, employment, 
emotional support, information sharing, internal locus of control, and positive perceptions of 
health status (Fields, 2007). Monitoring and good family relationships are key to protecting 
adolescents and young adults from using substances and becoming dependent after some time 
(Stone et al., 2012). 
On the other hand, stressful situations are common inside unbalanced family systems. 
These life events include the death of a parent, ending a relationship, a parent away at war, 
illness or mental health issues, criminal justice problems or financial problems (Stone et al., 
2012).  The influence of the family system during adolescence is significant since this life 
stage is characterized by several changes, biologically, psychologically and socially. 
Although some young people are able to use substances without suffering any significant 
problems, any stressor can be a trigger to start substance use. “One-third of the 1520 24-year-
old cohort participants had reported in adolescent interviews that they had used cannabis” 
(Swift, Coffey, Carlin, Degenhardt & Patton, 2008).  
Substance use can be a gateway to family or social problems during adolescence, 
starting with an initial contact that is usually influenced by peers. The next phase is 




factor, the process will continue to a stage of excessive use and finally, the stage of addiction 
(Fields, 2007). It is important to assess adolescents and young adults’ risk and protective 
factors for prevention and treatment, since early cannabis use is strongly linked to its abuse 
later in life. In an emerging adulthood study “more than half of the 521 adolescent users 
reported persistent use and two-thirds had commenced use by […] 15.9 years” (Swift et al., 
2008). 
Emerging adults 
Adulthood is usually characterized by three main features: accepting responsibilities, 
making decisions independently, and getting financial independence (Papalia & Feldman, 
2012). Yet, in the last years, technological development has forced adults to pursue a 
university or college degree in order to specialize their knowledge, which has affected their 
capacity of getting financial independence or full-time employment. This phenomenon, 
usually present in high income socioeconomic classes, has formed a new stage of human 
development, emerging adulthood. Emerging adulthood is a new concept that is of interest to 
many scientists since they have mixed features between adolescence and adulthood. This 
stage usually happens between the 18 and 25 years (Tanner & Arnett, 2009). 
Since emerging adulthood is now considered a transitional stage between adolescence 
and adulthood, some features include risky activities during peak periods like “drinking, 
illicit drug use, drunk or drugged driving, and casual sexual behavior” (Schwartz & Petrova, 
2019). The cognitive development during this stage is influenced by an exploratory manner 
of doing things, looking for possibilities and an opportunity to look for new and interesting 
activities. Individuals in emerging adulthood are experiencing the development of the brain’s 
center for reasoning and decision making, which is usually reached by age 25. This means 




(Tanner & Arnett, 2009). Plus, this also explains how emerging adults are very different from 
fully grown adults in relation to their information processing and emotion regulation. The 
physical status of emerging adults is commonly good; however, risky behaviors can have 
some negative consequences after this stage. In fact, most of the reported deaths within this 
age range are because of accidents (Papalia & Feldman, 2012). 
Therefore, research on prevention science has shown that emerging adults are perfect 
candidates for prevescalation, which is “the goal of preventing escalation in problem 
behavior rather than seeking only to prevent initiation” (Schwartz & Petrova, 2019). This is 
because emerging adults usually already started consuming drugs during their late 
adolescence, which will have a huge impact on their adult lives if not treated or controlled. It 
is said that emerging adults still have a trend to increase their drug use behavior from a 
weekly basis to a daily basis (Schwartz & Petrova, 2019). Thereby, illicit drug consumption 
reaches its highest peak between 18 and 25 years. This rate tends to decrease once they reach 
full adulthood and the settling down process continues, i.e. getting married or having a stable 
employment. Moreover, marijuana is the most common illicit drug used by emerging adults 
(Papalia & Feldman, 2012). Emotional lability correlates with substance use disorders within 
this age range, increasing the rates of comorbid mood disorders, like depression and/or 
anxiety (Schwartz & Petrova, 2019). 
Executive functions 
Frontal lobes are responsible for the organization of cognitive processes, function that 
can be named metacognition (Ardila & Rosselli, 2019). The functions that frontal lobes carry 
include emotions, motor control, eye movement control, and attentional control together with 
executive functions. Usually, frontal lobes work in coordination with other areas in the brain, 




lobes or emotions on the limbic system. There are various executive functions that are related 
to intellect, thought and self-control (Anderson, Jacobs & Anderson, 2010). However, for the 
purpose of this study, two analyses will be done, one based on a simple categorization of the 
most predominant executive functions and another based on the anatomical-functional 
organization of these metacognitive processes.  
Core Executive Functions 
Usually, neuropsychological textbooks and articles include several different processes 
such as working memory, contextual memory, inhibition, planning, generativity and 
cognitive flexibility (Stefanatos & Fein, 2017). These six specific domains on executive 
functions can be recategorized as three core executive functions.  
The first one is inhibition, which is related to the inhibition of automatic motor 
responses (Diamond, 2013). Inhibitory control as an executive function also includes the 
ability to select the attentional focus, control emotions and thoughts and be able to do what is 
appropriate within the social context. This means that the impairment on inhibitory control 
will affect the person by showing an impulsive behavior and low levels of attention on daily 
circumstances (Diamond, 2013). Generally, inhibition control is measured by giving 
activities with distractors and other temptations to stop doing them. The scores will be related 
to the capacity of the person to control impulses and continue with the activity, with 
minimum errors.  
The second core executive function is working memory. This type of memory is not 
included inside long-term or short-term memory categories. On the contrary, it is another 
type of memory that usually holds information necessary for an immediate work or action. 
There are two types of working memory, verbal and nonverbal (Diamond, 2013). Also, 




perception, such as information received by the senses that can be related to learnt 
circumstances in order to make plans and decisions (Ardila & Rosselli, 2019).  
The third core executive function is cognitive flexibility. This executive function is 
related to the other two core executive functions mentioned, since the main characteristic is 
the inhibition of a past perspective in order to accept and adapt to a new one, which will 
integrate information with working memory buffers (Diamond, 2013). Cognitive flexibility is 
also known as shifting, since in some activities, the person needs to shift their attention and 
concentration from one activity with certain rules, to a new one with different rules and 
characteristics (Ardila & Rosselli, 2019). This can be explained better by the assessment 
made by the Wisconsin Card Sorting Test. 
Functional anatomy of Executive Functions 
Some authors prefer to categorize executive functions by their anatomic localization, 
since it is believed that highly correlated executive functions are located in the same areas 
within the prefrontal cortex. This categorization is useful at the moment of assessing 
executive functions in patients, since damages to the prefrontal cortex can be focalized to a 
specific area. The global impairment of executive functions may not be a highly valid and 
reliable diagnosis, since the levels of disfunction can vary depending on which executive 
functions has been affected. Having said this, there are three main areas in the prefrontal 
cortex that are of interest for the purpose of this study.  
Flores, Ostrosky & Lozano (2014) state that the dorsolateral prefrontal cortex is an 
important region responsible for planning, working memory, fluency, complex problem 
solutions and mental flexibility. This means that most of the core executive functions 
mentioned are highly correlated with this area. The prefrontal cortex is a specialized area of 
the frontal lobe that englobes different levels of association between inputs and other areas of 




superior cognitive processes are also related to the dorsolateral prefrontal cortex, such as 
metacognition and adaptation to change. Summing-up the main functions that scientists have 
found in this area are working memory and selective attention/response (Diamond, 2013). 
Hence, impairment in this area relates to dysexecutive syndrome. 
The second region is the anterior prefrontal cortex, which is mainly responsible for 
inhibition processes, conflict solution and attentional regulation (Flores, Ostrosky & Lozano, 
2014). This area is connected mainly to the anterior cingulate cortex, which is located in the 
limbic system. The relationship between the frontal cortex and the limbic system creates the 
bond for the regulation of emotions and thoughts, as well as impulsive behaviors that are 
dominated by the amygdala and the reptilian brain. Also, its connection to the limbic system 
is important for Theory of Mind (ToM) processes, which are not part of executive functions, 
but still very important during neuropsychological assessment, especially for autism spectrum 
disorders (Stefanatos & Fein, 2017). In summary, the anterior prefrontal cortex is highly 
related to planning and self-initiated behavior. Consequently, impairment in this area leads to 
apathy and abulia. 
Finally, the third area is the orbitofrontal cortex. This area is located right in front of 
the olfactory cortex and is also highly related to the limbic system (Flores, Ostrosky & 
Lozano, 2014). Because of this, the orbitofrontal cortex is responsible of processing and 
regulating emotions, which includes behavioral regulation. Also, circuits regarding risk-
benefit decision making processes are within this cortex, since this area can also detect 
positive or negative changes in environmental conditions (Diamond, 2013). So, the 
orbitofrontal cortex is mainly responsible for decision-making processes. Thus, impairment 




Methodology and Research Design 
Design 
The current study aims to determine how and to what extent marijuana affects 
executive functions in Ecuadorian emerging adults that meet the criteria for chronic use of 
marijuana. The results found on this research will be analyzed quantitatively through a 
neuropsychological battery that consists of 15 different psychometric evaluations for 
different executive functions. There will be two different groups, a control group and a group 
of chronic marijuana users evaluated under the DSM-5 diagnostic criteria for substance use 
disorder, a demographic questionnaire, the CAST and the BANFE-2. 
The comparison and analysis of results will be done between subjects in two different 
levels. The first level of comparison will be made using average grades in each of the three 
specific areas that the battery assesses: orbitofrontal and medial prefrontal cortex, 
dorsolateral prefrontal cortex and anterior prefrontal cortex (Flores, Ostrosky & Lozano, 
2014). The second level of comparison will be done with the average total results of the 
executive functions area that the battery assesses, which is considered a global scoring of the 
whole battery. Scores obtained for each area and for the global area of the battery will be 
compared between the control group and the experimental group in order to obtain the 
significant differences for the numeric data that will test the hypothesis. 
Population 
30 Ecuadorian participants who personally report having problems with marijuana use 
disorder will be recruited to be a part of the research, which will be defined as using 
marijuana more days than not for the past three years. Both genders will be allowed to be 




will be between 18 and 25, with an average of 21.5 years old. Participation is voluntary and 
each one will be tested individually.  
Inclusion criteria: 
• Functioning role in society, i.e. gainful employment or regular attendance to 
college, university or technical education.  
Exclusion criteria: 
• Use of any other hard drug (cocaine, crack, meth, heroin) in the past year. 
• Present any co-occurring mental disorder in the past four years. 
Research Tools 
Informed consent will be signed at first instance by all participants who want to join. 
Then, participants will be diagnosed under the DSM-5 diagnostic criteria for substance use 
disorder (addiction). Later, a demographic questionnaire will be given to each participant in 
order to assess the rest of inclusion/exclusion criteria. Next, the CAST will be applied to each 
of the participants already inside the experiment in order to obtain qualitative characteristics 
of the chosen sample for discussion and analysis purposes. Finally, the neuropsychological 
battery BANFE-2 will be applied individually to every participant. 
DSM-5 
The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) is a diagnostic 
tool with the main objective of assisting trained clinicians in the analysis of a wide 
classification of mental disorders in order to obtain the most suitable diagnosis for each 
patient, thus the most adequate treatment option for them (American Psychiatric Association, 
2013). Most of the criteria found in the manual constitute a practical guide to comprehend the 
definition of a mental disorder as well as other “cognitive, emotional, behavioral, and 




diagnosis. These traits can also be analyzed as some signs or symptoms that are present in an 
underlying mental disorder. Other additional information for each disorder includes 
developmental history, risk factors within genetics or society and correlation with other 
neuropsychological and physiological processes. For the purposes of this research, the criteria 
used to assess participants will be those included under the category of cannabis-related 
disorders, specifically the cannabis use disorder (American Psychiatric Association, 2013). 
Demographic Questionnaire 
For the purpose of this research, a demographic questionnaire will be developed in 
order to assess additional inclusion/exclusion criteria within the participants. The 
demographic questionnaire will be included along with the CAST, where personal 
information will be asked to each of the participants. The information which the demographic 
questionnaire intends to collect will be age, sex, country of birth, years of education, current 
occupation, employment/studying status, and two yes/no questions on previous mental health 
diagnoses and consumption of any other hard drug in the last year. 
CAST 
The Cannabis Abuse Screening Test (CAST) is a self-administered questionnaire that 
assesses problematic use of cannabis (Cuenca-Royo et al., 2013). Its main purpose is to 
describe different aspects of harmful cannabis use, as well as screening of what could be 
stated as a problematic cannabis use. It was developed by the French Monitoring Centre for 
Drugs and Drug Addictions, with a sensitivity of 0.93 and a specificity of 0.81 (Annaheim & 
Legleye, 2017). There is a Spanish version that is widely used mainly in Spain, which is short 
and easy to respond, with a lot of components that are usually important within the young and 
young-adults population.  
The CAST-f, used in the present research,  is composed by 6 items and assesses the 




memory problems, attempts and motivations to reduce or stop the use of cannabis, and other 
problems related to the use of cannabis. Each item is answered on a Likert scale from 0 to 4, 
where 0 means never and 4 means always (Cuenca-Royo et al., 2013). The total score over 24 
is taken into account for the whole test, and cutoffs are 7 for moderate use and 9 for 
dependence (Cuenca-Royo et al., 2013). 
BANFE-2 
The Neuropsychological Battery of Executive Functions and Frontal Lobes-2 (Batería 
Neuropsicológica de Funciones Ejecutivas y Lóbulos Frontales-2, BANFE-2) is a 
psychometric battery used to assess different neuropsychological functions of cognitive 
processes that are under the control of the frontal lobes. Hence, executive functions are also 
included among these processes. BANFE-2 presents a large number of neuropsychological 
tests with high reliability and validity to assess frontal lobe processes (Flores, Ostrosky & 
Lozano, 2014) which are important for daily life activities such as planification, regulation 
and control of other psychological processes, as well as coordination and selection of 
strategies and behaviors. It was developed in Mexico by researchers at Universidad Nacional 
Autónoma de México and is also officially validated in Colombia.  
This tool aims to evaluate 15 processes related to executive functions in Spanish 
speakers, from 6-year-old children up to adulthood. All these 15 processes are divided in 
three specific areas, according to their functional and anatomical relationship. The first area is 
the orbitofrontal and medial prefrontal cortex, where three activities are measured such as 
Stroop test, gambling card game, and mazes. The second area is the dorsolateral prefrontal 
cortex, where nine activities are measured such as self-directed signaling, visuospatial 
working memory, alphabetical word ordering, card sorting, mazes, Hanoi tower, consecutive 




where three activities are measured such as semantic sorting, selection of proverbs, and 
metamemory (Flores, Ostrosky & Lozano, 2014). 
Each functional-anatomical area specified has its own scoring. The first step is to get 
the raw scores for each activity, and then normalize those scores with the tables provided in 
the Manual (Flores, Ostrosky & Lozano, 2014). Calculation of scoring can be done manually 
or electronically through the BANFE-2 website, where in the end, total scores for each area 
will be interpreted within the categories high normal, normal, mild-moderate alteration, and 
severe alteration. There are also total raw and normalized scores for the whole battery, which 
give a global diagnosis of executive functioning in the participant. It is important to state that 
normalized scores depend on age and the number of years of formal education that the 
participant has. 
Data collection 
Recruitment of participants will be done through social media, advertisements in 
different universities and direct visits to rehabilitation centers or mental health clinics. 
Participants who are currently battling an addiction, either on treatment or not, will receive 
the invitation to participate in the experiment from a USFQ psychology student. There will be 
a $20 financial incentive draw comprising all participants who are included in the 
investigation.  
The first step when receiving an interested participant is signing the informed consent 
where all the information, purposes and risks of the investigation will be explained. If the 
participant wants to continue, an interview will be done, where DSM-5 criteria will be 
evaluated in order to give a proper diagnosis of cannabis use disorder. This step would have 
an approximate duration of 10 minutes. If approved, the next stage is the application of 




is the application of the demographic questionnaire so as to get personal information 
regarding the inclusion/exclusion criteria. Completing the questionnaire will take 
approximately 5 minutes. Once the investigator confirms the participant is in compliance 
with all the inclusion criteria, and does not comply with the exclusion criteria, the next 
screening test will be applied. Since the CAST is a short self-administered test, it will be 
given to the participant after explaining what it consists of and how to respond to the items. 
This screening test will take approximately 5 minutes. Finally, the BANFE-2 will be 
administered by the investigator, starting in the order offered by the Manual (Flores, Ostrosky 
& Lozano, 2014) and answer sheets, which is:  
1. Mazes 
2. Self-directed signaling 
3. Alphabetical word ordering 
4. Consecutive subtraction 
5. Consecutive addition 
6. Card sorting 
7. Semantic sorting 
8. Stroop form A 
9. Verbal fluency 
10. Gambling card game 
11. Selection of proverbs 
12. Hanoi tower 
13. Metamemory 
14. Visuospatial working memory 




Some activities have time limits, while others do not. The approximate time that will 
take to complete the whole battery is 50 minutes, although it can extend some more when 
working with severe impaired patients (Flores, Ostrosky & Lozano, 2014). The investigator 
needs to follow the protocol in the Manual at all times so information is read accurately, and 
time limits are being respected. At the end, participants will be thanked for their time to the 
current research, and then scoring will be calculated to test the hypothesis. The total time it 
will take for a participant to complete all the stages is approximately 1 hour (60 minutes), in 
only one session. 
Data analysis 
Data analysis will be done in different aspects. The first aspect will be comparing 
average scores and standard deviations from the normalized subtotal scores for each area, 
between the control group and the experimental group. These are orbitofrontal and medial 
prefrontal cortex averages, anterior prefrontal cortex averages, and dorsolateral prefrontal 
cortex averages. Then, an analysis and comparison will be made between the total normalized 
score average for executive functions battery between both groups. Comparing the average 
scores in each area will determine if there is a specific effect of the chronic use of marijuana 
within the different executive functions. In contrast, comparing the total average scores 
between both groups will determine if there is a global impairment of these functions. 
However, it is also necessary to further analyze the averages for each area subtotal and the 
global average between the two groups in order to identify if there are significant differences 
in the scores obtained. So, four independent groups t-tests will be made and analyzed for each 
score. These analyses will test the following null hypothesis: there are no differences on 
executive functioning between chronic users of marijuana and control groups. Deeper 





The Institutional Review Board for Human Research at Universidad San Francisco de 
Quito (Comité de Ética USFQ) will examine the present study and verify that all ethical 
considerations are being respected at all times. An informed written consent will be prepared 
for the submission of this research proposal, which has to be approved by the board. All 
participants will be given the approved informed written consent which will explain all the 
objectives, risks and methods of the current study. Each participant who is personally 
encouraged to join the investigation will receive an identification code in order to maintain 
the participant’s identity and personal information fully confidential and anonymous. All the 
information collected in this study will be used for research purposes only. Participation is 
strictly voluntary with no negative implications for those who choose not to participate or 
retire at any time during the investigation. This means that, if for any reason any participant 
feels the need to leave the study, he or she is free to do so. 
Discussion 
The current research aims to answer the question “how and to what extent does 
marijuana affect the executive functions in the Ecuadorian emerging adults that meet the 
criteria for chronic use of marijuana?”. Numerous research have shown that the chronic use 
of alcohol and other hard drugs affect brain processes in different ways, mainly cognitive 
functions such as attention and memory. However, it is imperative to expand research on how 
a commonly used drug, such as marijuana, is affecting brain processes. Marijuana 
consumption has been increasing in the last years since therapeutic and recreational uses are 
been legalized around the globe (Du Plessis et al., 2015). Therefore, it is relevant for public 
health authorities to have information on the possible side effects on brain processes, 




to start or continue using Cannabis for different purposes. The emerging adulthood target 
group is also pertinent for the current research, since marijuana is the most consumed drug 
during adolescence (Papalia & Feldman, 2012), which means that emerging adults (18 to 25 
years old) will be directly related to the consumption of the drug in previous years. 
Endocannabinoid receptors play an important role in a lot of processes regarding the 
CNS (Harvey, 2012). The mimetic action of Cannabis with these receptors is the main reason 
why its effects on brain processes are of interest for research. Although intelligence quotient 
(IQ) has been studied in chronic use of some drugs (including marijuana), executive 
functions are other frontal lobe processes that are highly affected by the mentioned drug. 
Executive functions are important for human performance, since it includes all decision-
making processes that are made on a daily basis (Anderson et al., 2010). Also, it is known 
that dopaminergic pathways inside the brain are responsible for the addiction process as well 
as euphoric symptoms. In fact, frontal lobes are also included inside dopaminergic pathways 
in the brain (Volkow et al., 2011), which increases the possibility of an impairment on frontal 
lobe functioning when using a drug chronically. Therefore, there is evidence of a link 
between addiction or substance abuse and frontal lobe processes in the brain, i.e. executive 
functions. 
Based on the literature review done for this research, the application of a battery of 
neuropsychological tests that evaluate executive functions is essential to assess what is the 
real effect of the chronic use of marijuana on the aforementioned functions. There is even a 
stronger bond between executive functions and the use of drugs, which will open the doors 
for future investigation regarding causality, to determine if impairment on inhibition is the 
reason why certain people abuse the drug, or if the chronic abuse of the drug causes 




are affected, there could be a reason to choose consuming a drug over avoiding it. As 
expected, an impairment on global executive functioning will be found in patients. This 
global impairment will include low scores for functioning on working memory and selective 
attention in the dorsolateral prefrontal cortex, inhibition and planning on the anterior 
prefrontal cortex, and decision-making on the orbitofrontal cortex (Flores, Ostrosky & 
Lozano, 2014). Nevertheless, area-specific impairment can also be found in some users, since 
there is no concrete link between the areas mentioned in a neuropsychological functioning 
matter. 
Public health priorities are usually preventing diseases. But once the disease is present 
in the population, the main priority switches to healing or reducing pain. Regarding drug use 
and abuse, specifically marijuana, the main priority should include reducing dysfunctional 
behaviors that will perpetuate symptoms chronically or even increase the risk of premature 
death. Promptly finding the impairments on human functioning caused by a chronic use of 
marijuana will help authorities build new policies that include psychotherapy and possible 
neurocognitive rehabilitation therapy, which will reduce the impact of the drug on users. 
Nowadays, Ecuador has poor policies on addiction treatment (Delgado & Muentes, 2018), 
which is why is important to contribute with more research data on different drugs and 
intervention mechanisms, so that future policy-makers can take into account the cognitive 
problems that society is exposed to because of the legalization of medical and/or recreational 
use of marijuana. 
Strengths and limitations of proposal 
There is an important strength that should be identified in the current study. BANFE-2 
permits evaluators make a differential diagnosis between the distinctive functions that are 




and sometimes, it is difficult to understand the dissimilarity between these functions with 
separate tests that do not give the chance to integrate results. Also, the information collected 
for each function is related to their anatomical area within the prefrontal cortex, which will 
help on treatment focus for this group of patients.  
Nevertheless, there are some limitations that affect the precision of the results. The 
first limitation in this study regards the rapport between the participant and the evaluator. 
Although the first activities are simple, self-administered and do not require special training 
for evaluators, the context of relationship between the participant and the evaluator may alter 
the participant’s performance, hence, the results. For the main activity that is intended to 
assess all the functions of interest, BANFE-2, there is a standardized protocol that minimizes 
the evaluators influence on the participant. However, a special training is required for this. 
Finally, the second limitation of this study is related to the population. Most 
participants were from Quito, the city where the study was advertised and performed, which 
fails to accurately represent the Ecuadorian population. Also, the sample size was not large 
enough, which means that results may not be reliable for the whole population that this 
research intends to study. Lastly, BANFE-2 is a valid battery in Mexico and Colombia, but 
there is no strong validation of this test for the Ecuadorian population, which means that it 
may slightly change some real scores of the population, regarding the normalized values. 
Future implications 
Future research should be aimed to represent the whole Ecuadorian population, either 
focusing on different regions of the country or making larger and more diverse samples. 
Additionally, further analysis of the impaired functions should be made. Usually, participants 
within the selected group are seeking for therapy and abstinence periods. Retesting the 




if the effects found are reversible or not. Finally, the author hopes that this research opens the 
doors for more neurocognitive implications on substance use and abuse populations, 
specifically on neurocognitive rehabilitation tools and treatments plans for the areas that have 
been affected; so in the future there can be a combination between psychotherapy (e.g. 
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ANNEX A: Informed consent form and application to the IRB at USFQ 
 
Formulario de Consentimiento Informado por escrito 
 
Título de la investigación: The chronic use of marijuana and its effects on executive functions in emerging adulthood. 
Organizaciones que intervienen en el estudio: Universidad San Francisco de Quito 
Investigador Principal: Amilcar Mateo Cahueñas Bernal, 0992663080, acahuenasb@estud.usfq.edu.ec  
Co-investigadores: n/a 
 
DESCRIPCIÓN DEL ESTUDIO 
Introducción Debe tomarse en cuenta que el lenguaje que se utilice en este documento no puede ser subjetivo; debe ser lo más claro, conciso y 
sencillo posible; deben evitarse términos técnicos y en lo posible se los debe reemplazar con una explicación 
Este formulario incluye un resumen del propósito de este estudio. Usted puede hacer todas las preguntas 
que quiera para entender claramente su participación y despejar sus dudas.  Para participar puede tomarse 
el tiempo que necesite para consultar con su familia y/o amigos si desea participar o no.  
Usted ha sido invitado a participar en una investigación sobre los efectos en las funciones ejecutivas del 
consumo crónico de marihuana. 
Propósito del estudio Incluir una breve descripción del estudio, incluyendo el número de participantes, evitando términos técnicos e 
incluyendo solo información que el participante necesita conocer para decidirse a participar o no en el estudio 
 Se reclutarán 30 participantes con el objetivo de determinar cómo y en qué medida el consumo crónico de 
marihuana afecta las funciones ejecutivas de los adultos jóvenes.  
Descripción de los procedimientos para llevar a cabo el estudio Breve descripción de cada actividad en la que participarán 
los sujetos y el tiempo que tomará. No describir procesos en los que los participantes no tomarán parte. 
1. Reclutamiento de participantes voluntarios que cumplan con los criterios requeridos para el estudio.  
2. Realizar una entrevista de diagnóstico para evaluar los criterios de inclusión y determinar el consumo 
problemático de marihuana, durante 10 minutos. 
3. Aplicación de 2 evaluaciones globales: datos demográficos y CAST (consumo de marihuana), durante 10 
minutos. 
4. Aplicación del BANFE-2, una prueba de medida de funciones mentales, durante 50 minutos. 
5. Análisis de datos y conclusiones.  
 
Riesgos y beneficios Explicar los riesgos para los participantes en detalle, aunque sean mínimos, incluyendo riesgos físicos, emocionales y/o 
sicológicos a corto y/o largo plazo, detallando cómo el investigador minimizará estos riesgos; incluir además los beneficios tanto para los 
participantes como para la sociedad, siendo explícito en cuanto a cómo y cuándo recibirán estos beneficios 
No existen riesgos significativos para la salud mental o física de la persona. En algunas ocasiones, por el 
tiempo de aplicación de la batería neuropsicológica de funciones ejecutivas, podría presentarse cansancio, 
fatiga, dolor ocular o dolor de cabeza. Sin embargo, estos síntomas se podrán minimizar al tomarse un 
descanso de aproximadamente 10 minutos para poder continuar con el resto de las pruebas.  
Los participantes se beneficiarán de este estudio ya que no existen datos sobre el consumo de marihuana y 
sus efectos negativos en las funciones ejecutivas de los adultos emergentes. Por lo tanto, en Ecuador, hacen 
falta campañas de información y educación para que las personas sepan las consecuencias reales del 




crear un nuevo programa de intervención y tratamiento que incluya psicoterapia y rehabilitación 
neurocognitiva para las funciones afectadas.  
	
Confidencialidad de los datos Debe describirse cómo se protegerá el anonimato de los participantes, y también cómo se garantizará la 
seguridad de los datos en todas las etapas del estudio: reclutamiento, ejecución, análisis, publicación, postestudio (almacenamiento). Es importante 
explicar quién será el custodio de los datos recolectados.. 
Para nosotros es muy importante mantener su privacidad, por lo cual aplicaremos las medidas necesarias 
para que nadie conozca su identidad ni tenga acceso a sus datos personales: 
1) La información que nos proporcione se identificará con un código junto con su nombre y se guardará en 
un lugar seguro donde solo los investigadores mencionados al inicio de este documento tendrán acceso. 
Una vez finalizado el estudio se borrará su nombre y se mantendrán solo los códigos. 
2) Se removerá cualquier identificador personal que permita su identificación al reportar los datos 
obtenidos. 
4) Su nombre no será mencionado en los reportes o publicaciones. 
5) El Comité de ética de la investigación en seres humanos (CEISH) de la USFQ, podrá tener acceso a sus 
datos en caso de que surgieran problemas en cuando a la seguridad y confidencialidad de la información o 
de la ética en el estudio. 
6) Al finalizar el estudio los datos serán almacenados en una carpeta confidencial en la nube electrónica del 
investigador por 15 años. 
Derechos y opciones del participante  
Usted puede decidir no participar y si decide no participar solo debe decírselo al investigador principal o a la 
persona que le explica este documento. Además aunque decida participar puede retirarse del estudio 
cuando lo desee, sin que ello afecte los beneficios de los que goza en este momento. 
Usted no recibirá ningún pago ni tendrá que pagar absolutamente nada por participar en este estudio. Sin 
embargo, como forma de agradecimiento por su tiempo y esfuerzo, se incluirá su contacto en un sorteo de 
$20 que incluye a todos los participantes del grupo. 
Procedimientos para verificar la comprensión de la  información incluida  en este documento 
• ¿Puede explicarme cómo va a participar en este estudio? 
• ¿Qué hace si está participando y decide ya no participar? 
• ¿Cuáles son los posibles riesgos para usted si decide participar? ¿Está de acuerdo con estos riesgos? 
• ¿Qué recibirá por participar en este estudio? 
• ¿Hay alguna palabra que no haya entendido y desearía que se le explique? 
Información de contacto 
Si usted tiene alguna pregunta sobre el estudio por favor envíe un correo electrónico a 
acahuenasb@estud.usfq.edu.ec, que pertenece a Mateo Cahueñas Bernal. 
Si usted tiene preguntas sobre este formulario puede contactar al Dr. Iván Sisa, Presidente del CEISH-USFQ 










lenguaje	 claro	 y	 sencillo.	 Todas	 mis	 preguntas	 fueron	 contestadas.	 Me	 permitieron	 contar	 con	 tiempo	
suficiente	 para	 tomar	 la	 decisión	 de	 participar	 y	 me	 entregaron	 una	 copia	 de	 este	 formulario	 de	
consentimiento	informado.		Acepto	voluntariamente	participar	en	esta	investigación.	








































































ANNEX B: Demographic Questionnaire and Cannabis Abuse Screening Test (CAST) 
Código: __________ 
CAST (Cannabis Abuse Screening Test) en Español 
 
¿Con qué frecuencia te ha ocurrido algo de lo que se describe a 



















1. ¿Has consumido Cannabis antes 
del mediodía?       
2. ¿Has consumido Cannabis 
estando solo/a?       
3. ¿Has tenido problemas de 
memoria al fumar Cannabis?       
4. ¿Te han dicho tus amigos/as o 
miembros de tu familia que 












5. ¿Has intentado reducir o dejar de 










6. ¿Has tenido problemas debido a 
tu consumo de Cannabis (disputa, 



























Cuestionario de Datos Demográficos 
 
Edad (años y meses):  ____ años y _____ meses. 
Sexo:  Masculino ____     Femenino  ____  
País de Nacimiento:  ________________ 
Años de educación (marque con una X en el cuadro correspondiente): 
Universitaria o Superior completa (>17 años)  
Bachillerato completo (>12 años)  
Primaria completa (>8 años)  
Primaria incompleta (especifique el número de años):  ______  
 
Ocupación actual:  _____________________          
Marque con una X si actualmente estudia o trabaja, o ambas. 
Estudio:   ______     Trabajo:    _______ 
 
He tenido un diagnóstico previo realizado por un profesional en salud mental (psicólogo, 
psiquiatra, neurólogo, etc.):                                Sí ___       No ___ 
 
He consumido cualquier droga fuerte (cocaína, heroína, éxtasis, metanfetaminas) en los 
últimos 12 meses:          Sí ___        No ___ 
